Conjugated Estrogens Monograph Withdrawal Would Be Premature - Duramed

Wyeth-Ayerst's efforts to have the U.S. Pharmacopoeia monographs on conjugated estrogens withdrawn "insinuat[es] that it will not fulfill its responsibility to conclusively identify the active ingredients in its product any time soon," Duramed alleges in an Aug. 4 response to a Wyeth petition.